top of page

F&A – Where the Action Is

The foot and ankle market segment is now, for the first time, considered one of the most lucrative orthopedic segments.

$2-$5 billion, annually

Current estimates put the U.S and worldwide foot and ankle market shares north of $2 billion, and $5 billion, respectively. Annual growth rates are equally as impressive, ranging from 6% to 10%, according to the "Foot And Ankle Devices Global Market Report 2022."


Consolidation will continue

Stryker's acquisition of Wright Medical started the trend. Envois, DePuy Synthes, ConMed, Medartis, and Acumed all followed suit with acquisitions of their own, further setting the stage.


Competition is good

  • Patient-specific implants/guides

  • Intraoperative guidance systems

  • Renewed interest in minimally invasive surgery

  • New bioabsorbable implants that may supplant traditional fixation

  • Novel closure innovations

Contentious competition is all but certain.

Recent Posts

See All

Wound Care Business in Crisis

BioAventis has agreed to sell its wound business to LifeNet Health, which includes skin substitutes TheraSkin and TheraGenesis. The transaction includes a total cash consideration of $85 million. Indu

Foot and Ankle Leadership News

Dr. Ned Amendola MD, FAAOS, FRCS(C) from Duke University was named second vice president of the American Academy of Orthopedic Surgeons (AAOS) and will ascend to president in 2025-2026. Fellowship tra

Novastep Deal Consumated

As speculated in February 2023 FIX, Enovis announced early this week that it has consummated a deal for Novastep with the MIS bunion system being the prize along with access to a robust OUS sales chan

Comments


FIX Masthead 2000x318 v2.jpg
bottom of page